Year 816 (DCCCXVI) was a leap year starting on Tuesday of the Julian calendar, the 816th year of the Common Era (CE) and Anno Domini (AD) designations, the 816th year of the 1st millennium, the 16th year of the 9th century, and the 7th year of the 810s decade.

What happened and who was notable in 816 AD? Browse important events, world leaders, notable birthdays, and tragic deaths from the year 816 AD.

816工程遗址，位于重庆市涪陵区白涛街道，紧邻乌江，背靠武陵山。 1966年由中央军委、周恩来总理批准建设，该工程打山洞用时8年，安装设备用时9年，总投资7.46亿元人民币。

2024年6月5日 · Background: The phase 3 CheckMate 816 study established neoadjuvant NIVO + chemo as a standard of care for eligible pts with resectable NSCLC. Here, we report the 4-year survival update from this study, representing the longest follow-up among all global phase 3 studies evaluating neoadjuvant or perioperative immunotherapy-based treatments.

2019年10月14日 · The 816 Nuclear Reactor was Communist China 's first foray into building its own nuclear reactor capable of producing weapons-grade plutonium without Soviet assistance.

The earliest mention in English records is an entry in the Anglo-Saxon Chronicle for the year 816 where it states the Schola burned down. The Liber Pontificalis says the fire was due to the carelessness of the Saxons and nearly spread to St. Peter’s.

In the year 816, Europe was rocked by several events that had a profound impact on the region. Perhaps the most significant event of the year occurred on October 5th, when King Louis the Pious was crowned emperor of the Holy Roman Empire by Pope Stephen IV in Reims.

2022年4月18日 · 在此，我们报告了 CheckMate 816 的结果，这是一项 3 期试验，用于评估新辅助纳武利尤单抗联合化疗（3 个周期）与单独化疗（3 个周期）在可切除 NSCLC 患者中的疗效和安全性。 方法： 在这项开放标签的 3 期试验中，我们将 IB 期患者随机分配到 IIIA 期可切除 NSCLC，分别接受纳武利尤单抗加铂类化疗或单用铂类化疗，然后进行切除。 主要终点是无事件生存期（EFS）和病理完全缓解（pCR） （切除的肺和淋巴结中的存活肿瘤为 0%），两者均 …

Articles and events specifically related to the year 816. Wikimedia Commons has media related to Category:816.

2022年4月11日 · CheckMate 816 builds on robust findings for nivolumab-based regimens in advanced NSCLC 12-14 and a strong biologic rationale for use in resectable NSCLC, especially in the neoadjuvant context. 15...